Pharmacological treatments for fatigue in patients with multiple sclerosis: A systematic review and meta-analysis
Authors:
- 1 September 2017
- journal article
- research article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 380, 256-261
Abstract
No abstract availableKeywords
Funding Information
- National Science Foundation of Chongqing Science and Technology Commission (cstc2016jcyjA1406)
This publication has 17 references indexed in Scilit:
- Comparison of the effect of aspirin and amantadine for the treatment of fatigue in multiple sclerosis: a randomized, blinded, crossover studyNeurological Research, 2012
- HAGIL (Hamburg Vigil Study): a randomized placebo-controlled double-blind study with modafinil for treatment of fatigue in patients with multiple sclerosisMultiple Sclerosis Journal, 2011
- Modafinil effects in multiple sclerosis patients with fatigueJournal of Neurology, 2009
- Fampridine-SR in multiple sclerosis: a randomized, double-blind, placebo-controlled, dose-ranging studyMultiple Sclerosis Journal, 2007
- Modafinil for fatigue in MSNeurology, 2005
- Comparison of the effects of acetyl l-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double-blind, crossover trialJournal of the Neurological Sciences, 2004
- Management of Fatigue in Patients with Multiple SclerosisDrugs, 2004
- The Effects of Amantadine and Pemoline on Cognitive Functioning in Multiple SclerosisArchives of Neurology, 1996
- Fatigue therapy in multiple sclerosisNeurology, 1995
- A Randomized Controlled Trial of Amantadine in Fatigue Associated With Multiple SclerosisCanadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, 1987